Assessment of Bet v 1-specific CD4+ T cell responses in allergic and nonallergic individuals using MHC class II peptide tetramers

Journal of Immunology

Volumn 180, Issue 7, 2008, Pages 4514-4522

  Van Overtvelt, Laurence ^a   Wambre, Erik ^b   Maillère, Bernard ^b   Von Hofe, Eric ^f   Louise, Anne ^c   Balazuc, Anne Marie ^c   Bohle, Barbara ^g   Ebo, Didier ^h   Leboulaire, Christophe ^d   Garcia, Gilles ^e   Moingeon, Philippe ^a,i  

^a Stallergenes SA   (France)

^b DIF   (France)

^c INSTITUT PASTEUR   (France)

^d BECKMAN COULTER INC   (United States)

^e HÔPITAL ANTOINE BÉCLÈRE   (France)

^f Antigen Express   (United States)

^g MEDICAL UNIVERSITY OF VIENNA   (Austria)

^h UNIVERSITY OF ANTWERP   (Belgium)

ⁱ Staller gènes   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; EPITOPE; GAMMA INTERFERON; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 5; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE; POLLEN ANTIGEN; POLLEN ANTIGEN BET V 1; TETRAMER; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; ALLERGEN; CYTOKINE; HLA ANTIGEN CLASS 2; PEPTIDE FRAGMENT; VEGETABLE PROTEIN;

ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CELL CLONE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; IMMUNE RESPONSE; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; POLLEN ALLERGY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SEASONAL VARIATION; TH2 CELL; AMINO ACID SEQUENCE; BIOSYNTHESIS; CELL CULTURE; CELL PROLIFERATION; CHEMISTRY; CYTOLOGY; HYPERSENSITIVITY; IMMUNOLOGY; MOLECULAR GENETICS; PHENOTYPE;

ALLERGENS; AMINO ACID SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; HYPERSENSITIVITY; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PHENOTYPE; PLANT PROTEINS;

EID: 44449145067     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.7.4514     Document Type: Article

References (57)

1. El Biaze, M., S. Boniface, V. Koscher, E. Mamessier, P. Dupuy, F. Milhe, M. Ramadour, D. Vervloet, and A. Magnan. 2003. T cell activation, from atopy to asthma: more a paradox than a paradigm. Allergy 58: 844-853.
2. Schleimer, R. P., C. P. Derse, B. Friedman, S. Gillis, M. Plaut, L. M. Lichtenstein, and D. W. MacGlashan, Jr. 1989. Regulation of human basophil mediator release by cytokines: I. Interaction with antiinflammatory steroids. J. Immunol. 143: 1310-1317.
3. Walker, C., J. C. Virchow, Jr., P. L. Bruijnzeel, and K. Blaser. 1991. T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma. J. Immunol. 146: 1829-1835.
4. Hakansson, L., C. Heinrich, S. Rak, and P. Venge. 1997. Priming of eosinophil adhesion in patients with birch pollen allergy during pollen season: effect of immunotherapy. J. Allergy Clin. Immunol. 99: 551-562.
5. Hakansson, L., C. Heinrich, S. Rak, and P. Venge. 1998. Activation of B-lym- phocytes during pollen season: effect of immunotherapy. Clin. Exp. Allergy 28:791-798.
6. + T cells in primary culture: relationship to expression of allergic disease. J. Allergy Clin. Immunol. 99: 563-569.
7. Bohle, B., T. Kinaciyan, M. Gerstmayr, A. Radakovics, B. Jahn-Schmid, and C. Ebner. 2007. Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation. J. Allergy Clin. Immunol. 120: 707-713.
8. Ciprandi, G., D. Fenoglio, I. Cirillo, A. Vizzaccaro, A. Ferrera, M. A. Tosca, and F. Puppo. 2005. Induction of interleukin 10 by sublingual immunotherapy for house dust mites: a preliminary report. Ann. Allergy Asthma Immunol. 95: 38-44.
9. Ciprandi, G., D. Fenoglio, I. Cirillo, M. A. Tosca, R. M. La, A. Licari, A. Marseglia, S. Barberi, and G. L. Marseglia. 2007. Sublingual immunotherapy: an update on immunologic and functional effects. Allergy Asthma Proc. 28:40-43.
10. Cosmi, L., V. Santarlasci, R. Angeli, F. Liotta, L. Maggi, F. Frosali, O. Rossi, P. Falagiani, G. Riva, S. Romagnani, et al. 2006. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-γ- and interleukin-10-production. Clin. Exp. Allergy 36: 261-272.
11. + T cells by grass pollen immunotherapy. J. Allergy Clin. Immunol. 111: 1255-1261.
12. Jutel, M., M. Akdis, F. Budak, C. Aebischer-Casaulta, M. Wrzyszcz, K. Blaser, and C. A. Akdis. 2003. IL-10 and TGF-β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur. J. Immunol. 33: 1205-1214.
13. Larche, M., C. A. Akdis, and R. Valenta. 2006. Immunological mechanisms of allergen-specific immunotherapy. Nat. Rev. Immunol. 6: 761-771.
14. Moingeon,P.,T. Batard,R. Fadel, F. Frati,J. Sieber, andL. VanOvertvelt. 2006. Immune mechanisms of allergen-specific sublingual immunotherapy. Allergy 61:151-165.
15. + cells are detectable in allergic, but not in nonallergic, individuals. J. Immunol. 176: 5069 -5077.
16. + T cells. J. Allergy Clin. Immunol. 118: 1350-1356.
17. Kinnunen, T., K. Jutila, W. W. Kwok, M. Rytkönen-Nissinen, A. Immonen, S. Saarelainen, A. Närvänen, A. Taivainen, and T. Virtanen. 2007. Potential of an altered peptide ligand of lipocalin allergen Bos d 2 for peptide immunotherapy. J. Allergy Clin. Immunol. 119: 965-972.
18. Bakker, A. H., and T. N. Schumacher. 2005. MHC multimer technology: current status and future prospects. Curr. Opin. Immunol. 17: 428 -433.
19. McMichael, A. J., and A. Kelleher. 1999. Thearrival ofHLAclass IItetramers. J. Clin. Invest. 104: 1669-1670.
20. + T cells with optimized HLA class II tetramer staining. J. Immunol. 175: 6334-6343.
21. Yang, J., E. A. James, L. Huston, N. A. Danke, A. W. Liu, and W. W. Kwok. 2006. Multiplex mapping of CD4 T cell epitopes using class II tetramers. Clin. Immunol. 120: 21-32.
22. Akkerdaas, J. H., R. R. van, M. Aalbers, S. O. Stapel, and R. C. Aalberse. 1995. Multiplicity of cross-reactive epitopes on BetvIasdetected with monoclonal antibodies and human IgE. Allergy 50: 215-220.
23. Swoboda, I., A. Jilek, F. Ferreira, E. Engel, K. Hoffmann-Sommergruber, O. Scheiner, D. Kraft, H. Breiteneder, E. Pittenauer, and E. Schmid. 1995. Iso- forms of Bet v 1, the major birch pollen allergen, analyzed by liquid chroma- tography, mass spectrometry, and cDNA cloning. J. Biol. Chem. 270: 2607-2613.
24. Kallinteris, N. L., X. Lu, C. E. Blackwell, E. von Hofe, R. E. Humphreys, and M. Xu. 2006. Ii-Key/MHC class II epitope hybrids: a strategy that enhances MHC class II epitope loading to create more potent peptide vaccines. Expert Opin. Biol. Ther. 6: 1311-1321.
25. Batard, T., A. Didierlaurent, H. Chabre, N. Mothes, L. Bussieres, B. Bohle, M. N. Couret, T. Ball, P. Lemoine, T. M. Focks, et al. 2005. Characterization of wild-type recombinant Bet v 1a as a candidate vaccine against birch pollen allergy. Int. Arch. Allergy Immunol. 136: 239 -249.
26. Zetterquist, H., and O. Olerup. 1992. Identification of the HLA-DRB1*04, -DRB1*07, and -DRB1*09 alleles by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Hum. Immunol. 34: 64-74.
27. Castelli, F. A., C. Buhot, A. Sanson, H. Zarour, S. Pouvelle-Moratille, C. Nonn, H. Gahery-Segard, J. G. Guillet, A. Menez, B. Georges, and B. Maillere. 2002. HLA-DP4, the most frequent HLA II molecule, defines a new supertype of pep- tide-binding specificity. J. Immunol. 169: 6928-6934.
28. Texier, C., S. Pouvelle, M. Busson, M. Herve, D. Charron, A. Menez, and B. Maillere. 2000. HLA-DR restricted peptide candidates for bee venom immunotherapy. J. Immunol. 164: 3177-3184.
29. Fourneau, J. M., H. Cohen, and P. M. van Endert. 2004. A chaperone-assisted high yield system for the production of HLA-DR4 tetramers in insect cells. J. Immunol. Methods 285: 253-264.
30. Ebner, C., S. Schenk, N. Najafian, U. Siemann, R. Steiner, G. W. Fischer, K. Hoffmann, Z. Szepfalusi, O. Scheiner, and D. Kraft. 1995. Nonallergic individuals recognize the same T cell epitopes of Bet v 1, the major birch pollen allergen, as atopic patients. J. Immunol. 154: 1932-1940.
31. 142-156 is the dominant T-cell epitope of the major birch pollen allergen and important for cross-reactivity with Bet v 1-related food allergens. J. Allergy Clin. Immunol. 116: 213-219.
32. Ebner, C., S. Schenk, Z. Szepfalusi, K. Hoffmann, F. Ferreira, M. Willheim, O. Scheiner, and D. Kraft. 1993. Multiple T cell specificities for Bet v I, the major birch pollen allergen, within single individuals: studies using specific T cell clones and overlapping peptides. Eur. J. Immunol. 23: 1523-1527.
33. Wambre, E., L. Van Overtvelt, B. Maillière, R. Humphreys, E. Von Hofe, L. Ferhat, D. Ebo, and P. Moingeon. 2008. Single cell assessment of allergen- specific T cell responses with MHC-class II peptide tetramers: methodological aspects. Int. Arch. Allergy Immunol. 146: 99 -112.
34. Campbell, J. D., V. Gangur, F. E. Simons, and K. T. HayGlass. 2004. Allergic humans are hyporesponsive to a CXCR3 ligand-mediated Th1 immunity-promoting loop. FASEB J. 18: 329-331
35. Samoilova, E. B., J. L. Horton, H. Zhang, S. J Khoury, H. L. Weiner and Y. Chen. 1998. CTLA-4 is required for the induction of high dose oral tolerance. Int. Immunol. 10: 491-498.
36. Ahern, D. J., and D. S. Robinson. 2005. Regulatory T cells as a target for induction of immune tolerance in allergy. Curr. Opin. Allergy Clin. Immunol. 5:531-536.
37. Akdis, C. A., K. Blaser, and M. Akdis. 2006. Mechanisms of allergen-specific immunotherapy. Chem. Immunol. Allergy 91: 195-203.
38. Cools, N., P. Ponsaerts, V. Van Tendeloo, and Z. N. Berneman. 2007. Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells. J. Leukocyte Biol. 82: 1365-1374.
39. Romagnani, S. 2006. Regulatory T cells: which role in the pathogenesis and treatment of allergic disorders? Allergy 61: 3-14.
40. Stock, P., R. H. DeKruyff, and D. T. Umetsu. 2006. Inhibition of the allergic response by regulatory T cells. Curr. Opin. Allergy Clin. Immunol. 6: 12-16.
41. Taylor, A., J. Verhagen, K. Blaser, M. Akdis, and C. A. Akdis. 2006. Mechanisms of immune suppression by interleukin-10 and transforming growth fac- tor-β: the role of T regulatory cells. Immunology 117: 433-442.
42. Umetsu, D. T., and R. H. DeKruyff. 2006. The regulation of allergy and asthma. Immunol. Rev. 212: 238 -255.
43. van Oosterhout, A. J., and N. Bloksma. 2005. Regulatory T-lymphocytes in asthma. Eur. Respir. J. 26: 918 -932.
44. Verhagen, J., A. Taylor, K. Blaser, M. Akdis, and C. A. Akdis. 2005. Tregulatory cells in allergen-specific immunotherapy. Int. Rev. Immunol. 24: 533-548.
45. + T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model. J. Exp. Med. 182: 1579-1584.
46. Sakaguchi, S., and F. Powrie. 2007. Emerging challenges in regulatory T cell function and biology. Science 317: 627-629.
47. + regulatory T cells from peripheral Foxp3" precursors. Blood 110: 4293-4302.
48. Dormann, D., E. Montermann, L. Klimek, B. Weber, C. Ebner, R. Valenta, D. Kraft, and A. B. Reske-Kunz. 1997. Heterogeneity in the polyclonal T cell response to birch pollen allergens. Int. Arch. Allergy Immunol. 114: 272-277.
49. Ebner, C., U. Siemann, N. Najafian, O. Scheiner, and D. Kraft. 1995. Characterization of allergen (Bet v 1)-specific T cell lines and clones from non-allergic individuals. Int. Arch. Allergy Immunol. 107: 183-185.
50. Akdis, M., J. Verhagen, A. Taylor, F. Karamloo, C. Karagiannidis, R. Crameri, S. Thunberg, G. Deniz, R. Valenta, H. Fiebig, et al. 2004. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J. Exp. Med. 199: 1567-1575.
51. Bullens, D. M., A. De Swerdt, E. Dilissen, A. Kasran, R. A. Kroczek, P. Cadot, P. Casaer, and J. L. Ceuppens. 2005. House dust mite-specific T cells in healthy non-atopic children. Clin. Exp. Allergy 35: 1535-1541.
52. + T cells proliferating to grass pollen in seasonal allergic subjects by flow cytometry. Clin. Exp. Immunol. 132: 76-80.
53. Bacchetta, R., E. Gambineri, and M. G. Roncarolo. 2007. Role of regulatory T cells and FOXP3 in human diseases. J. Allergy Clin. Immunol. 120: 227-235.
54. Nocentini, G., S. Ronchetti, S. Cuzzocrea, and C. Riccardi. 2007. GITR/GITRL: more than an effector T cell co-stimulatory system. Eur. J. Immunol. 37:1165-1169.
55. + T cells. Cell. Mol. Immunol. 3: 189-195.
56. Scott-Taylor, T. H., J. B. Hourihane, J. Harper, and S. Strobel. 2005. Patterns of food allergen-specific cytokine production by T lymphocytes of children with multiple allergies. Clin. Exp. Allergy 35: 1473-1480.
57. Romagnani, S. 2007. Coming back to a missing immune deviation as the main explanatory mechanism for the hygiene hypothesis. J. Allergy Clin. Immunol. 119: 1511-1513.